LONDON, Aug. 05, 2022 (GLOBE NEWSWIRE) -- As the pandemic crisis has entered a new phase, it is a common belief among the scientific community that COVID-19 is here to stay, maybe for a long time. Many scientists expect the virus that causes ...
Read More ...PALO ALTO, Calif. , Aug. 5, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, ...
Read More ...ATLANTA , Aug. 5, 2022 /PRNewswire/ -- Earlier this week, Kansas voters rejected a proposed constitutional amendment that would have removed the right to abortion from the Kansas Constitution. For the sake of Black women's physical, ...
Read More ...OTTAWA,ON, TRADITIONAL UNCEDED ALGONQUIN TERRITORY , Aug. 5, 2022 /CNW/ - COVID-19 case numbers are increasing with the current seventh wave, and it is impacting communities across the country. Indigenous Services Canada remains available to ...
Read More ...BEIJING , Aug. 5, 2022 /PRNewswire/ -- On 5 th August, WeTrade Group Inc. ("Wetrade" or the "Company") (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent ...
Read More ...New results demonstrate a newer class of anti-IgE antibody, UB-221, with superior neutralization, synthesis reduction, and durable relief in targeting allergic diseases TAIPEI , Aug. 5, 2022 /PRNewswire/ -- United BioPharma (UBP) today ...
Read More ...NOVI, Mich. , Aug. 4, 2022 /PRNewswire/ -- An estimated 2.5 million people suffer Traumatic Brain Injuries (TBI) annually in the United States with children, young adults and senior citizens being the most vulnerable. U. S. military ...
Read More ...The nonprofit will support women in underserved communities by providing free contraceptives, reproductive health services, and resources ORLANDO, Fla. , Aug. 4 , 2022 /PRNewswire-PRWeb/ -- Hazel Walker Foundation (HWF), a nonprofit ...
Read More ...What people eat or don't eat is the biggest risk factor for morbidity and mortality. But rising prices are straining household finances and increasing the threat of food insecurity. The American College of Lifestyle Medicine (ACLM) is offering ...
Read More ...Effective immediately, Exam Master announces the release of a fee assistance program for the Physician Assistant College Admissions Test (PA-CAT). For economically eligible candidates, this program provides a significant discount off of the ...
Read More ...The initiative will enable JBRC to help increase the community's access to medications for substance use disorder. MAYS LANDING, N.J. , Aug. 4 , 2022 /PRNewswire-PRWeb/ -- John Brooks Recovery Center (JBRC) has received a $1 million ...
Read More ...The National Association for Child Development announces the re-release of their popular NACD Home Speech Therapist's Speech Therapy for Apraxia app, which has been a top medical app across the globe. The app is available on the Apple store. ...
Read More ...In an August 2 feature in Tech Company News, stem cell biotechnology company Asymmetrex®'s CEO disclosed the company's plans to release its first generation of online calculators for rapid counting of therapeutic tissue stem cells. The company ...
Read More ...New Investment from Forbion and Sofinnova Partners MANCHESTER, England , Aug. 4, 2022 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat ...
Read More ...ADESOS is a Phase 2b dose-finding study of orismilast modified release (MR) tablet in moderate to severe atopic dermatitis (AD) with the purpose of identifying the appropriate dose-regimen for Phase 3 studies AD is the most common chronic ...
Read More ...HANGZHOU, China and SHAOXING, China , Aug. 3, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the Investigational New Drug (IND) application of ASC10 , an oral inhibitor drug candidate targeting ...
Read More ...The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy, is pleased to announce the publication ...
Read More ...First procedures were successfully performed under local anesthesia in an office setting by Steven Gange MD FACS, Summit Urology, Utah . YOKNEAM, Israel , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Butterfly Medical , an Israeli medical ...
Read More ...More than half of pregnant and breastfeeding women nationwide believe there is not enough awareness surrounding the existence of lactation support services. ASHEVILLE, N.C. , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Aeroflow Breastpumps , a ...
Read More ...RESEARCH TRIANGLE PARK, N.C. , Aug. 3, 2022 /PRNewswire/ -- A new study by experts at RTI International, a nonprofit research institute, estimates that a one-year increase in alcohol consumption during the COVID-19 pandemic will have a ...
Read More ...- Commentary points to need for a vaccine based on nucleocapsid vs. spike protein to make vaccine less vulnerable to mutation and provide stronger immunity to novel viral variants - Company's development of a nucleocapsid vaccine, a ...
Read More ...Enable Biosciences Reports Easier and Accurate SARS-CoV-2 Neutralizing Antibody Assay using Dried Blood Spot Samples SOUTH SAN FRANCISCO, Calif. , Aug. 3, 2022 /PRNewswire/ -- Scientists at Enable Biosciences report a novel method to ...
Read More ...CAMBRIDGE, Mass. , Aug. 3, 2022 /PRNewswire/ -- Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, today announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for ...
Read More ...HANGZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that its innovative drug LNK01004, has been approved by ...
Read More ...- STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. - STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea , Aug. 3, 2022 ...
Read More ...SUZHOU, China , Aug. 3, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the ...
Read More ...Bened Life, Inc. releases its first product, Neuralli™ SAN FRANCISCO , Aug. 3, 2022 /PRNewswire-PRWeb/ -- Bened Life is releasing the first gut-brain medical probiotic, Neuralli™, on Wednesday, August 3, 2022 . Made in the United States ...
Read More ...KEY POINTS TADIOS was determined to be safe and well tolerated Serum levels of IL-1RA changed significantly, a biomarker that has a correlation with severity and mortality during COVID-19 infections Improvement in fatigue observed LA ...
Read More ...VIKEN, Sweden , Aug. 3, 2022 /PRNewswire/ -- A new study with TikoMed's lead drug candidate, ILB®, addressing underlying causes of neurodegeneration in acute and chronic diseases, was published in the International Journal of Molecular ...
Read More ...-- ASC10 is an oral double prodrug that is rapidly and completely converted in vivo into the active metabolite ASC10-A, which is the same active metabolite of molnupiravir -- Ascletis has filed multiple patent applications for ASC10 and its ...
Read More ...HAMBURG, Germany , Aug. 3, 2022 /PRNewswire/ -- Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya (NPHL) as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund. ...
Read More ...Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2022
This site complies with the HONcode standard for trustworthy health information:
verify here.
Careers
